Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000532839 | SCV000626179 | uncertain significance | Fanconi anemia | 2022-08-10 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1000 of the FANCA protein (p.His1000Gln). This variant is present in population databases (rs750421982, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 456107). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FANCA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001330801 | SCV001522615 | uncertain significance | Fanconi anemia complementation group A | 2019-11-20 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genetic Services Laboratory, |
RCV001821478 | SCV002067580 | uncertain significance | not specified | 2018-11-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004691846 | SCV005193012 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000532839 | SCV002092563 | uncertain significance | Fanconi anemia | 2020-02-12 | no assertion criteria provided | clinical testing |